Sign in
Taking people in United KingdomNo phase

Studies causes of polycystic ovary syndrome and related pregnancy problems

Observes women with polycystic ovary syndrome to study its underlying causes and related problems.

Key facts

Who runs it
University of Oxford
Where
Oxford, United KingdomSee the site
Trial code
Registry title
Reproductive Endocrinology Oxford Study (RepOx)
Status
Recruiting
People taking part
1,175 people, planned
Started
21 Oct 2021
Expected to end
1 Sept 2028
Type of study
Observational, 10 groups
Record updated
4 January 2022

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for women aged 16 to 45 with or under investigation for polycystic ovary syndrome (PCOS). It also enrols women with repeated miscarriage, pregnancy complications, and comparison groups.

Age
16 to 45 years (18 to 45 years for women having IVF)
Sex
Women only
Disease stage
Several groups: PCOS (or under investigation for it), at least two miscarriages, gestational diabetes or intrahepatic cholestasis of pregnancy from 28 weeks of pregnancy, and comparison groups without these conditions.
Biomarker or test result
Groups with gestational diabetes or cholestasis of pregnancy need raised blood glucose or raised liver enzyme (ALT) and bile acid levels, as listed in the record.

Main reasons for not taking part

  • Cannot read or understand written or spoken English
  • Currently in a clinical trial of an investigational medicine
  • Having surgery because of a possible cancer
  • Another condition with too much androgen, such as congenital adrenal hyperplasia, androgen-secreting tumours, Cushing syndrome or hyperprolactinemia

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • ● General Criteria for all groups; Participant is willing and able to give informed consent for participation in the study; Female, aged between 16 and 45 years of age. As IVF is not undertaken in women less that 18 years, this group will between 18 and 45 years o; ● PCOS (Group 1, 2 and 3); Currently under investigation for or having diagnosis of PCOS having displayed one or more of the following: Hyperandrogenism, Ovulation Dysfunction and Polycystic ovaries on ultrasound (known as the Rotterdam criteria); ● PCOS Controls (Group 4 and 5); Patients under gynaecological investigation or having assisted reproduction; Exhibit no features of PCOS; ● Miscarriage Group (Group 6); Have had at least two previous miscarriages; Recruited at any time after their second menstrual cycle following a miscarriage; ● Miscarriage Controls (Group 7); Patients will have had zero or no more than one miscarriage and having fertility investigations; ● Pregnant GDM (Group 8); Pregnant women at least 28 weeks gestation with :; 1) A fasting plasma glucose of 5.1mmol/L or above or; 2) A 1 hr plasma glucose of 10mmol/L or; 3) A 2-hr plasma glucose level of 8.5mmol/L or above; ● Pregnant ICP (Group 9); Women at least 28 weeks gestation with :; Raised ALT or raised bile acids in the context of pruritus with no rash; ALT (>32iu/l) and bile acids (>14micromol/l) Pregnant Control (Group 10); Pregnant women at least 28 weeks gestation with no diagnosis of GDM or ICP

Who cannot take part

  • For all groups - The participant may not enter the study if ANY of the following apply; Unable to read, or to understand written or spoken English; Currently involved in any Clinical Trial of an Investigational Medicinal Product (CTIMP); Undergoing surgery because of a possible cancer diagnosis; Diagnosis of other androgen excess disorders such as Congenital Adrenal Hyperplasia (CAH), Androgen Secreting tumours, Cushing syndrome, or Hyperprolactinemia

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 16 and 45 years old?

Where in United Kingdom

  • Nuffield Department Women's and Reproductive HealthOxford, United KingdomContact: OSPREA -Study Research MidwivesTaking people

About the trial

What the trial wants to find out

This is a prospective observational study that aims to identify the underlying mechanisms of PolyCystic Ovarian Syndrome (PCOS) and associated comorbidities such as subfertility, miscarriage; and pregnancy complications such as gestational diabetes mellitus and Intrahepatic cholestasis of pregnancy (ICP). This will be achieved through cross-sectional observation and laboratory analyses.

The 10 groups in the trial

  • PCOS

    No intervention.

  • PCOS surgery

    No intervention

  • Surgery control

    No intervention

  • IVF PCOS

    No intervention

  • IVF control

    No intervention

  • Investigations, fertility PCOS

    No intervention

  • Investigations, fertility control

    No intervention

  • Pregnancy - gestational diabetes mellitus

    No intervention

  • Pregnancy - Intrahepatic cholestasis of pregnancy

    No intervention

  • Pregnancy - control

    No intervention

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Reproductive Endocrinology Oxford Study (RepOx)
Plain-language title
Studies causes of polycystic ovary syndrome and related pregnancy problemsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT05177562, who can take part
Record updated
4 January 2022